XtalPi: China has clear advantages in developing AI-driven drugs

Chinese companies have an edge in developing drugs with the help of AI, thanks to the country's advanced hardware, talent pool, and robust supply chain, according to Wen Shuhao, co-founder and chairman of XtalPi. He noted that this made China a favorable option for international businesses expanding in this field.

Search Trends